TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Herantis Pharma Oyj
Closing information (x1000 DKK)
| Closing information | 2016/12 (consolidated) | 2015/12 | 2013/12 |
| Turnover | 186 | 0 | |
| Financial expenses |
617
|
36,311
|
209 |
| Earnings before taxes |
-32,897
|
-115,567
|
-5,827 |
| Total assets |
75,868
|
107,015
|
19,705 |
| Current assets |
5,814
|
3,097
|
321 |
| Current liabilities |
4,557
|
2,798
|
4,999 |
| Equity capital |
11,709
|
79,532
|
895 |
| - share capital |
595
|
597
|
22 |
| Employees (average) |
7
|
5
|
3 |
Financial ratios
| Fiscal year | 2016/12 (consolidated) | 2015/12 | 2013/12 |
| Solvency |
15.4%
|
74.3%
|
4.5% |
| Turnover per employee | 27 | 0 | |
| Profit as a percentage of turnover | -17686.6% | ||
| Return on assets (ROA) |
-42.5%
|
-74.1%
|
-28.5% |
| Current ratio |
127.6%
|
110.7%
|
6.4% |
| Return on equity (ROE) |
-281.0%
|
-145.3%
|
-651.1% |
| Change turnover | |||
| Change turnover % | |||
| Chg. No. of employees | |||
| Chg. No. of employees % | 67% |
Total value of public sale
| Fiscal year | 2016/12 (consolidated) | 2015/12 | 2013/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.